Correlation Between Regencell Bioscience and Zomedica Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Zomedica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Zomedica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regencell Bioscience Holdings and Zomedica Pharmaceuticals Corp, you can compare the effects of market volatilities on Regencell Bioscience and Zomedica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Zomedica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Zomedica Pharmaceuticals.

Diversification Opportunities for Regencell Bioscience and Zomedica Pharmaceuticals

-0.15

Correlation Coefficient

Regencell Bioscience  Zomedica Pharmaceuticals

Good diversification

The 3 months correlation between Regencell and Zomedica is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Zomedica Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zomedica Pharmaceuticals and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Zomedica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zomedica Pharmaceuticals has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Zomedica Pharmaceuticals go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Zomedica Pharmaceuticals

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to generate 2.27 times more return on investment than Zomedica Pharmaceuticals. However, Regencell Bioscience is 2.27 times more volatile than Zomedica Pharmaceuticals Corp. It trades about 0.04 of its potential returns per unit of risk. Zomedica Pharmaceuticals Corp is currently generating about 0.02 per unit of risk. If you would invest  655.00  in Regencell Bioscience Holdings on September 3, 2024 and sell it today you would lose (23.00) from holding Regencell Bioscience Holdings or give up 3.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regencell Bioscience Holdings  vs.  Zomedica Pharmaceuticals Corp

Regencell Bioscience

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

Zomedica Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Zomedica Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Zomedica Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Regencell Bioscience and Zomedica Pharmaceuticals

The main advantage of trading using opposite Regencell Bioscience and Zomedica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Zomedica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zomedica Pharmaceuticals will offset losses from the drop in Zomedica Pharmaceuticals' long position.

The idea behind Regencell Bioscience Holdings and Zomedica Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.